← Leaderboards
Patrick Reichenberger
Cypress Biopharma, Inc.
$305,786
Attributed
$305,786
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$305,786 · 1
By mechanism
R41$305,786 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Actins”
- Raul Padron · Univ Of Massachusetts Med Sch Worcester$4,501,962
- Baodong Sun · Duke University$2,697,948
- Lindsay Case · Massachusetts Institute Of Technology$2,381,060
- Qing Tang · University Of Nebraska Lincoln$2,041,875
- Callie S Kwartler · University Of Texas Hlth Sci Ctr Houston$1,962,238
- Ryan David Wuebbles · Strykagen Corporation$1,953,245
Research focus
ActinsAgonistAlternative TherapiesAnimal ModelAreaAutoimmuneBehavioralBenchmarkingBindingBinding ProteinsBiologicalBiological AvailabilityBiologyBlood FilterCardiotoxicityCell DeathCell InjuryChildChildhoodClinical TranslationCommercializationCopingCypressAcceleration